Xtreme Laboratories Private Limited
About Xtreme Laboratories Private Limited
Data last updated:
Xtreme Laboratories Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 23 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PTC066025. Its GSTIN is 24AAACX1189J1Z6 (Gujarat).
The company has an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Sandeep C Palan and Amishkumar Rameshchandra Changela.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.5 Sojitranagar Opp. Golden Super Market Near New Era School Raiya Road, Rajkot, Gujarat, India – 360007.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.77 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹68,864 (net margin 0.4%) and EBITDA of ₹9.08 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Xtreme Laboratories Private Limited's registered office is in Rajkot, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.5 Sojitranagar Opp. Golden Super Market Near New Era School Raiya Road, Rajkot, Gujarat, India – 360007
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Xtreme Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xtreme Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Xtreme Laboratories Private Limited, buy the company report.
Financials of Xtreme Laboratories Private Limited
FY 2025 filings availableXtreme Laboratories Private Limited reported revenue of ₹1.77 Cr (up 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 18% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68,864 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xtreme Laboratories Private Limited, buy the company report.
Board of directors of Xtreme Laboratories Private Limited
Xtreme Laboratories has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep C Palan | Director | 23 Jun 2011 | 15 Years 4 Months | Current |
| Amishkumar Rameshchandra Changela | Director | 23 Jun 2011 | 15 Years 4 Months | Current |
| Chetan Chandarana | Director | 23 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Xtreme Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I.Q. Med Healthcare Private Limited | ₹1.78 Cr (FY 2020) | -55.0% | New Delhi, Delhi, India | |||
| Leogard Pharmaceuticals Private Limited | ₹1.77 Cr (FY 2025) | -37.0% | Kalyan, Maharashtra, India | |||
| Xtreme Laboratories Private Limitedthis company | ₹1.77 Cr (FY 2024) | ₹68,864 | 0.4% | 18.0% | Rajkot, Gujarat, India | |
| Cognitive Life Sciences Private Limited | ₹1.75 Cr (FY 2022) | 29.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Xtreme Laboratories Private Limited, buy the company report.
Auditor
Xtreme Laboratories Private Limited is audited by DODIYA MEHTA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DODIYA MEHTA & CO. | FY 2017 | 120662W |
Shareholding
The shareholding of Xtreme Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Xtreme Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xtreme Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xtreme Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xtreme Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACX1189J1Z6 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xtreme Laboratories Private Limited, buy the company report.
Recent activity
Xtreme Laboratories Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Amishkumar Rameshchandra Changela was appointed as Director on 23 Jun 2011.
Frequently asked questions
Xtreme Laboratories is an active private limited company based in Rajkot, Gujarat, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 23 June 2011 (15+ years old) and is registered under CIN U24230GJ2011PTC066025.
Xtreme Laboratories has 3 current directors:
- Sandeep C Palan - Director
- Amishkumar Rameshchandra Changela - Director
- Chetan Chandarana - Director
The latest financial statements of Xtreme Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xtreme Laboratories is 24AAACX1189J1Z6, registered in Gujarat.
The CIN (Corporate Identification Number) of Xtreme Laboratories is U24230GJ2011PTC066025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xtreme Laboratories was incorporated on 23 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Xtreme Laboratories by revenue are I.Q. Med Healthcare Private Limited, Leogard Pharmaceuticals Private Limited, Cognitive Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (other hospital and medical care activities).
Amishkumar Rameshchandra Changela was appointed as Director on 23 Jun 2011. Chetan Chandarana was appointed as Director on 23 Jun 2011. Sandeep C Palan was appointed as Director on 23 Jun 2011.
The registered office of Xtreme Laboratories is at Shop No.5 Sojitranagar Opp. Golden Super Market Near New Era School Raiya Road, Rajkot, Gujarat, India – 360007.
Xtreme Laboratories operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Xtreme Laboratories is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.